As of May 05
| -0.28 / -4.20%|
The 6 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 12.50, with a high estimate of 19.00 and a low estimate of 8.50. The median estimate represents a +95.92% increase from the last price of 6.38.
The current consensus among 6 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.